1 Standard Chemotherapy + Mitazalimab, More Than 90% Effective In The Treatment Of Pancreatic Cancer! May 15, 2025
2 Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma May 12, 2025
3 Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment! May 10, 2025
4 Chemotherapy May Promote Resistance To Immunotherapy In Pancreatic Cancer, Study Shows May 07, 2025
Read More Apparatus World's First Antibody Targeting B7H7 Approved For Clinical Trial In The Us Jun 18, 2025
